BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32015482)

  • 1. Low blood pressure and cardiovascular events in diabetic patients with coronary artery disease after revascularization: the CREDO-Kyoto registry cohort-1.
    Kai H; Katoh A; Harada H; Niiyama H; Furukawa Y; Kimura T;
    Hypertens Res; 2020 Jul; 43(7):715-723. PubMed ID: 32015482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low DBP may not be an independent risk for cardiovascular death in revascularized coronary artery disease patients.
    Kai H; Ueno T; Kimura T; Adachi H; Furukawa Y; Kita T; Imaizumi T;
    J Hypertens; 2011 Oct; 29(10):1889-96. PubMed ID: 21857536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Low Diastolic Blood Pressure on Risk of Cardiovascular Death in Elderly Patients With Coronary Artery Disease After Revascularization - The CREDO-Kyoto Registry Cohort-1.
    Kai H; Kimura T; Fukuda K; Fukumoto Y; Kakuma T; Furukawa Y;
    Circ J; 2016 Apr; 80(5):1232-41. PubMed ID: 27053493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
    Kjeldsen SE; Berge E; Bangalore S; Messerli FH; Mancia G; Holzhauer B; Hua TA; Zappe D; Zanchetti A; Weber MA; Julius S
    Blood Press; 2016; 25(2):83-92. PubMed ID: 26511535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization in the FREEDOM Trial.
    Esper RB; Farkouh ME; Ribeiro EE; Hueb W; Domanski M; Hamza TH; Siami FS; Godoy LC; Mathew V; French J; Fuster V
    J Am Coll Cardiol; 2018 Dec; 72(23 Pt A):2826-2837. PubMed ID: 30522646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of polyvascular disease on clinical outcomes in patients undergoing coronary revascularization: an observation from the CREDO-Kyoto Registry Cohort-2.
    Morikami Y; Natsuaki M; Morimoto T; Ono K; Nakagawa Y; Furukawa Y; Sakata R; Aota M; Okada Y; Onoe M; Kawasuji M; Koshiji T; Nakajima H; Nishizawa J; Yamanaka K; Yamamoto H; Kimura T;
    Atherosclerosis; 2013 Jun; 228(2):426-31. PubMed ID: 23623262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could intensive anti-hypertensive therapy produce the "J-curve effect" in patients with coronary artery disease and hypertension after revascularization?
    Lu W
    Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1350-5. PubMed ID: 27097958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk and Blood Pressure Control Rates Across the Spectrum of Coronary Artery Disease in Hypertensive Women: An Analysis from The INternational VErapamil SR-Trandolapril STudy (INVEST).
    Sava RI; Chen YE; Smith SM; Gong Y; Cooper-DeHoff RM; Keeley EC; Pepine CJ; Handberg EM
    J Womens Health (Larchmt); 2020 Feb; 29(2):158-166. PubMed ID: 31403360
    [No Abstract]   [Full Text] [Related]  

  • 9. Management and clinical outcome of stable coronary artery disease in Austria : Results from 5 years of the CLARIFY registry.
    Lang IM; Badr-Eslam R; Greenlaw N; Young R; Steg PG
    Wien Klin Wochenschr; 2017 Dec; 129(23-24):879-892. PubMed ID: 28913755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis.
    Bangalore S; Messerli FH; Franklin SS; Mancia G; Champion A; Pepine CJ
    Eur Heart J; 2009 Jun; 30(11):1395-401. PubMed ID: 19351690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous coronary intervention in diabetic versus non-diabetic patients with prior coronary artery bypass grafting: a propensity score matching study.
    Ma X; Dong R; Chen P; Zhao Y; Zeng C; Xin M; Ye Q; Wang J
    BMC Cardiovasc Disord; 2020 Apr; 20(1):159. PubMed ID: 32252636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year outcomes of surgical or percutaneous myocardial revascularization in diabetic patients.
    Contini GA; Nicolini F; Fortuna D; Pacini D; Gabbieri D; Vignali L; Valgimigli M; Manari A; Zussa C; Guastaroba P; De Palma R; Grilli R; Gherli T
    Int J Cardiol; 2013 Sep; 168(2):1028-33. PubMed ID: 23164591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target Blood Pressure in Patients with Diabetes: Asian Perspective.
    Park S; Kario K; Park CG; Huang QF; Cheng HM; Hoshide S; Wang JG; Chen CH;
    Yonsei Med J; 2016 Nov; 57(6):1307-11. PubMed ID: 27593856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships Between Components of Blood Pressure and Cardiovascular Events in Patients with Stable Coronary Artery Disease and Hypertension.
    Vidal-Petiot E; Greenlaw N; Ford I; Ferrari R; Fox KM; Tardif JC; Tendera M; Parkhomenko A; Bhatt DL; Steg PG
    Hypertension; 2018 Jan; 71(1):168-176. PubMed ID: 29084876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between visit-to-visit blood pressure variability and adverse events in coronary artery disease patients after coronary intervention.
    Tsai TY; Leu HB; Hsu PF; Yang YL; Chen SC; Huang SS; Chan WL; Lin SJ; Chen JW; Pan JP; Charng MJ; Chen YH; Wu TC; Lu TM; Huang PH; Cheng HM; Huang CC; Sung SH; Lin YJ; Wu CH
    J Clin Hypertens (Greenwich); 2022 Oct; 24(10):1327-1338. PubMed ID: 36094363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure level associated with lowest cardiovascular event in hypertensive diabetic patients.
    Lee CJ; Hwang J; Lee YH; Oh J; Lee SH; Kang SM; Choi D; Kim HC; Park S
    J Hypertens; 2018 Dec; 36(12):2434-2443. PubMed ID: 30015754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation between fractional flow reserve value of coronary lesions with deferred revascularization and cardiovascular outcomes in non-diabetic and diabetic patients.
    Liu Z; Matsuzawa Y; Herrmann J; Li J; Lennon RJ; Crusan DJ; Kwon TG; Zhang M; Sun T; Yang S; Gulati R; Bell MR; Lerman LO; Lerman A
    Int J Cardiol; 2016 Sep; 219():56-62. PubMed ID: 27281577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure and mortality after percutaneous coronary intervention: a population-based cohort study.
    Lee CW; Lee JK; Choi YJ; Kim H; Han K; Jung JH; Kim DH; Park JH
    Sci Rep; 2022 Feb; 12(1):2768. PubMed ID: 35177716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions≤50% versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Oct; 114(7):988-96. PubMed ID: 25124184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
    Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ;
    Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.